GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
Z20.822
Contact with and (suspected) exposure to COVID-19
ICD10CM code
Medical Policies and Guidelines for Contact with and (suspected) exposure to COVID-19
Related policies from health plans
CIGNA
COVID-19: In Vitro Diagnostic Testing - (0557)
Similar Codes
ICD10CM codes
Z20.822
- Contact with and (suspected) exposure to COVID-19
Z20.9
- Contact with and (suspected) exposure to unspecified communicable disease
Z20.828
- Contact with and (suspected) exposure to other viral communicable diseases
Z20
- Contact with and (suspected) exposure to communicable diseases
Z20.8
- Contact with and (suspected) exposure to other communicable diseases
Z20.82
- Contact with and (suspected) exposure to other viral communicable diseases
Z20.89
- Contact with and (suspected) exposure to other communicable diseases
Z20.821
- Contact with and (suspected) exposure to Zika virus
Z20.1
- Contact with and (suspected) exposure to tuberculosis
Z20.820
- Contact with and (suspected) exposure to varicella
HCPCS codes
U0004
- 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (i
U0003
- Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavir
C9803
- Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavir
U0005
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavir
G2023
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus di
G2024
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus di
G8482
- Influenza immunization administered or previously received
U0002
- 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (i
Q2039
- Influenza virus vaccine, not otherwise specified
D0190
- Screening of a patient
CPT4 codes
86769
- Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-1
87811
- Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; seve
0240U
- Infectious disease (viral respiratory tract infection), pathogen-specific rna, 3 targets (severe acu
0223U
- Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid
4037F
- Influenza immunization ordered or administered (COPD, PV, CKD, ESRD)(IBD)
0202U
- Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid
87635
- Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavir
87290
- Infectious agent antigen detection by immunofluorescent technique; Varicella zoster virus
99072
- Additional supplies, materials, and clinical staff time over and above those usually included in an
86328
- Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single-step method